L10.2 Pemphigus Foliaceus - Causes and Treatment
L10.2 is the ICD-10 code for pemphigus foliaceus, a rare autoimmune skin disease causing superficial blisters and erosions on the skin.
Things worth knowing about "L10.2"
L10.2 is the ICD-10 code for pemphigus foliaceus, a rare autoimmune skin disease causing superficial blisters and erosions on the skin.
What is L10.2 (Pemphigus Foliaceus)?
L10.2 is the ICD-10 diagnosis code for pemphigus foliaceus, a rare, chronic autoimmune blistering disease of the skin. In this condition, the immune system mistakenly attacks structures within the skin, leading to the formation of superficial blisters and open sores. Unlike other forms of pemphigus, the mucous membranes (such as the mouth or eyes) are generally not affected.
Causes
Pemphigus foliaceus is an autoimmune disease. The immune system produces autoantibodies, typically of the IgG class, that target desmoglein 1, a protein responsible for holding skin cells together in the upper layers of the skin (epidermis). When this protein is attacked, the skin cells lose their adhesion and blisters develop. The exact trigger for this immune malfunction is not fully understood, but known contributing factors include:
- Genetic predisposition (certain HLA types)
- Certain medications (e.g., penicillamine, captopril)
- UV radiation as a possible environmental trigger
- Rarely, infectious agents
Symptoms
The typical symptoms of pemphigus foliaceus include:
- Superficial, easily ruptured blisters on the skin, most commonly on the face, scalp, back, and chest
- Erosions and crusting after the blisters break open
- Pain and burning sensations in affected skin areas
- A scaly, raw appearance of the skin
- No or minimal involvement of mucous membranes
Diagnosis
Diagnosis of pemphigus foliaceus involves a combination of clinical examination and laboratory testing:
- Skin biopsy: Histological examination of a blister sample to identify splitting in the upper layers of the epidermis
- Direct immunofluorescence (DIF): Detection of IgG antibodies on the surface of skin cells
- Indirect immunofluorescence and ELISA: Detection of anti-desmoglein 1 antibodies in the blood serum
- Clinical differentiation from other blistering disorders such as pemphigus vulgaris (L10.0) or bullous pemphigoid (L12.0)
Treatment
Pemphigus foliaceus is a chronic condition that typically requires long-term management. Treatment aims to suppress the autoimmune response and prevent the formation of new blisters:
Systemic Therapy
- Corticosteroids (e.g., prednisolone) as the first-line treatment for rapid suppression of inflammation
- Immunosuppressants such as azathioprine, mycophenolate mofetil, or methotrexate to reduce the required steroid dose
- Rituximab (a monoclonal antibody) for severe or treatment-resistant cases
- Intravenous immunoglobulins (IVIG) in selected cases
Local (Topical) Therapy
- Wound care and skin management to prevent secondary infections
- Topical corticosteroids for mild disease
Prognosis
Pemphigus foliaceus generally follows a chronic course but can be well controlled with appropriate therapy. In drug-induced cases, discontinuation of the causative medication may lead to complete remission. Without treatment, the disease can become life-threatening due to large-scale skin loss, which can result in serious infections and fluid imbalance.
References
- Hertl M. et al. - Pemphigus. In: Braun-Falco's Dermatology, Venereology and Allergology. Springer, 2018.
- Schmidt E., Zillikens D. - Pemphigous diseases. The Lancet, 2013; 381(9863):320-332.
- Murrell D.F. et al. - Diagnosis and Management of Pemphigus: Recommendations by an International Panel of Experts. Journal of the American Academy of Dermatology, 2020; 82(3):575-585.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMost read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: L10.2